Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q1 2025 Earnings Call Transcript May 8, 2025
Xeris Biopharma Holdings, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.07.
Operator: Good morning. Thank you for attending today’s Xeris Biopharma Holdings, Inc. First Quarter 2025 Results Conference Call. My name is Makaya, and I’ll be the moderator for today’s call. All lines will be muted during the presentation portion of the call with an opportunity for your...
